Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioma | 22 | 2024 | 3455 | 2.990 |
Why?
|
Brain Neoplasms | 30 | 2024 | 9030 | 2.790 |
Why?
|
Central Nervous System Neoplasms | 9 | 2024 | 916 | 2.210 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2022 | 491 | 2.150 |
Why?
|
Ribonuclease III | 4 | 2022 | 278 | 1.270 |
Why?
|
Astrocytoma | 5 | 2023 | 775 | 1.220 |
Why?
|
DEAD-box RNA Helicases | 4 | 2022 | 383 | 1.180 |
Why?
|
Sarcoma, Clear Cell | 2 | 2023 | 72 | 1.010 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 4 | 2022 | 269 | 0.890 |
Why?
|
Oncogene Proteins, Fusion | 9 | 2023 | 1605 | 0.890 |
Why?
|
Choriocarcinoma | 1 | 2022 | 121 | 0.800 |
Why?
|
Germinoma | 1 | 2022 | 132 | 0.780 |
Why?
|
Transducin | 1 | 2020 | 42 | 0.740 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 5 | 2024 | 147 | 0.730 |
Why?
|
Sturge-Weber Syndrome | 5 | 2024 | 89 | 0.720 |
Why?
|
Receptor, trkB | 1 | 2020 | 124 | 0.670 |
Why?
|
Capillaries | 4 | 2024 | 755 | 0.650 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2018 | 20 | 0.630 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 123 | 0.630 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2023 | 2052 | 0.580 |
Why?
|
Infratentorial Neoplasms | 1 | 2018 | 98 | 0.580 |
Why?
|
RNA-Binding Protein EWS | 2 | 2021 | 210 | 0.550 |
Why?
|
Autopsy | 2 | 2020 | 1006 | 0.540 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2019 | 245 | 0.540 |
Why?
|
Gene Fusion | 3 | 2023 | 356 | 0.540 |
Why?
|
Myxoma | 1 | 2017 | 114 | 0.540 |
Why?
|
Child | 44 | 2024 | 80156 | 0.530 |
Why?
|
Histiocytoma, Malignant Fibrous | 3 | 2021 | 55 | 0.510 |
Why?
|
Retinoblastoma | 1 | 2018 | 317 | 0.510 |
Why?
|
Brain Stem Neoplasms | 3 | 2022 | 190 | 0.480 |
Why?
|
Neuroblastoma | 2 | 2024 | 1250 | 0.470 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 471 | 0.470 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 502 | 0.470 |
Why?
|
Child, Preschool | 28 | 2024 | 42251 | 0.470 |
Why?
|
Wilms Tumor | 1 | 2017 | 379 | 0.450 |
Why?
|
Mutation | 25 | 2024 | 30044 | 0.420 |
Why?
|
Vascular Neoplasms | 1 | 2014 | 166 | 0.420 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2014 | 147 | 0.420 |
Why?
|
Ependymoma | 3 | 2021 | 320 | 0.420 |
Why?
|
Sarcoma | 2 | 2022 | 1793 | 0.420 |
Why?
|
Histones | 4 | 2022 | 2579 | 0.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2024 | 3638 | 0.410 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2023 | 42 | 0.400 |
Why?
|
Hirschsprung Disease | 1 | 2013 | 163 | 0.390 |
Why?
|
Pituitary Gland, Anterior | 1 | 2012 | 142 | 0.390 |
Why?
|
Repressor Proteins | 2 | 2021 | 2985 | 0.390 |
Why?
|
Infant | 21 | 2024 | 36202 | 0.380 |
Why?
|
Proto-Oncogene Proteins | 3 | 2023 | 4509 | 0.370 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2897 | 0.370 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2012 | 169 | 0.360 |
Why?
|
Enteric Nervous System | 1 | 2013 | 212 | 0.360 |
Why?
|
Osteolysis | 1 | 2012 | 275 | 0.350 |
Why?
|
Adenoma, Oxyphilic | 1 | 2012 | 148 | 0.350 |
Why?
|
Rhabdoid Tumor | 2 | 2024 | 210 | 0.340 |
Why?
|
Prognosis | 12 | 2024 | 29588 | 0.340 |
Why?
|
Adolescent | 26 | 2024 | 88305 | 0.330 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2024 | 938 | 0.330 |
Why?
|
Immunohistochemistry | 5 | 2023 | 11070 | 0.330 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1897 | 0.330 |
Why?
|
Cell Transdifferentiation | 1 | 2010 | 185 | 0.330 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2017 | 2060 | 0.320 |
Why?
|
Death, Sudden | 2 | 2022 | 302 | 0.320 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2413 | 0.320 |
Why?
|
Rectum | 1 | 2013 | 892 | 0.320 |
Why?
|
Osteoclasts | 1 | 2012 | 711 | 0.310 |
Why?
|
Humans | 82 | 2024 | 761326 | 0.310 |
Why?
|
Glioblastoma | 4 | 2024 | 3482 | 0.300 |
Why?
|
Vascular Malformations | 3 | 2024 | 468 | 0.300 |
Why?
|
Medical Oncology | 1 | 2019 | 2321 | 0.290 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4908 | 0.290 |
Why?
|
Cerebellar Neoplasms | 2 | 2024 | 586 | 0.280 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2804 | 0.270 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.270 |
Why?
|
Young Adult | 19 | 2024 | 59196 | 0.250 |
Why?
|
Central Nervous System | 3 | 2022 | 1337 | 0.250 |
Why?
|
Hemangioma | 2 | 2021 | 727 | 0.250 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1959 | 0.240 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1405 | 0.240 |
Why?
|
Neural Stem Cells | 1 | 2012 | 888 | 0.230 |
Why?
|
Melanoma | 1 | 2023 | 5706 | 0.230 |
Why?
|
Male | 39 | 2024 | 360621 | 0.230 |
Why?
|
Receptor, EphB2 | 1 | 2023 | 26 | 0.230 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1346 | 0.230 |
Why?
|
Receptor, EphB4 | 1 | 2023 | 39 | 0.230 |
Why?
|
Encephalomyelitis, Equine | 1 | 2023 | 13 | 0.220 |
Why?
|
Encephalitis Virus, Eastern Equine | 1 | 2023 | 12 | 0.220 |
Why?
|
Calmodulin | 1 | 2024 | 218 | 0.220 |
Why?
|
Encephalitis, Viral | 1 | 2023 | 58 | 0.220 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2023 | 56 | 0.220 |
Why?
|
Pituitary Neoplasms | 1 | 2012 | 1324 | 0.210 |
Why?
|
West Nile virus | 1 | 2023 | 76 | 0.210 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2023 | 88 | 0.210 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 2019 | 0.210 |
Why?
|
Female | 39 | 2024 | 392485 | 0.210 |
Why?
|
Brain | 6 | 2024 | 27103 | 0.210 |
Why?
|
Soft Tissue Neoplasms | 2 | 2021 | 1156 | 0.210 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2022 | 45 | 0.200 |
Why?
|
Histiocytic Disorders, Malignant | 1 | 2022 | 14 | 0.200 |
Why?
|
Oncogene Fusion | 2 | 2019 | 81 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 1 | 2024 | 461 | 0.190 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 428 | 0.190 |
Why?
|
Chordoma | 1 | 2024 | 346 | 0.190 |
Why?
|
Sudden Infant Death | 1 | 2024 | 291 | 0.190 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2023 | 259 | 0.180 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 172 | 0.180 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2021 | 64 | 0.180 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 180 | 0.180 |
Why?
|
Proteomics | 2 | 2024 | 3843 | 0.180 |
Why?
|
Encephalitis | 1 | 2024 | 438 | 0.170 |
Why?
|
Adult | 24 | 2024 | 221122 | 0.170 |
Why?
|
Chemokines | 1 | 2024 | 960 | 0.170 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 370 | 0.170 |
Why?
|
Lymphoproliferative Disorders | 1 | 2023 | 533 | 0.170 |
Why?
|
Neocortex | 1 | 2023 | 417 | 0.160 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2023 | 389 | 0.160 |
Why?
|
Language Development Disorders | 1 | 2020 | 193 | 0.160 |
Why?
|
Transcription Factors | 1 | 2018 | 12122 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9275 | 0.160 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12972 | 0.150 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 349 | 0.150 |
Why?
|
Frameshift Mutation | 1 | 2020 | 392 | 0.150 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 253 | 0.150 |
Why?
|
Mycoplasma hominis | 1 | 2017 | 10 | 0.150 |
Why?
|
Choroid Plexus Neoplasms | 1 | 2018 | 38 | 0.150 |
Why?
|
Neurons | 3 | 2020 | 9458 | 0.150 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 159 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 350 | 0.150 |
Why?
|
Methylation | 1 | 2020 | 1082 | 0.150 |
Why?
|
Oligodendroglioma | 1 | 2019 | 279 | 0.150 |
Why?
|
Choroid Neoplasms | 1 | 2019 | 177 | 0.150 |
Why?
|
Mycoplasma Infections | 1 | 2017 | 120 | 0.150 |
Why?
|
Neurofibromatosis 1 | 1 | 2022 | 560 | 0.140 |
Why?
|
Empyema, Pleural | 1 | 2017 | 61 | 0.140 |
Why?
|
Cytoplasm | 2 | 2012 | 1511 | 0.140 |
Why?
|
Endothelial Cells | 5 | 2024 | 3543 | 0.140 |
Why?
|
Ciliary Body | 1 | 2018 | 167 | 0.140 |
Why?
|
Translocation, Genetic | 1 | 2023 | 1393 | 0.140 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 637 | 0.140 |
Why?
|
Teratoma | 1 | 2020 | 404 | 0.140 |
Why?
|
Infant, Newborn | 6 | 2024 | 26211 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 612 | 0.140 |
Why?
|
Histone Demethylases | 1 | 2019 | 320 | 0.140 |
Why?
|
Arteriovenous Fistula | 1 | 2019 | 319 | 0.130 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2019 | 366 | 0.130 |
Why?
|
Choroid | 1 | 2019 | 360 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2024 | 954 | 0.130 |
Why?
|
Lysine | 1 | 2020 | 991 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1127 | 0.130 |
Why?
|
Aneuploidy | 1 | 2019 | 551 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 703 | 0.130 |
Why?
|
Myocytes, Cardiac | 1 | 2024 | 1671 | 0.130 |
Why?
|
Neural Tube Defects | 1 | 2017 | 254 | 0.130 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4108 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2024 | 80575 | 0.120 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2018 | 332 | 0.120 |
Why?
|
Pathology, Molecular | 1 | 2018 | 328 | 0.120 |
Why?
|
Medulloblastoma | 1 | 2020 | 678 | 0.120 |
Why?
|
Cell Differentiation | 4 | 2023 | 11531 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 520 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2019 | 774 | 0.120 |
Why?
|
Age of Onset | 1 | 2021 | 3303 | 0.120 |
Why?
|
Biomedical Research | 2 | 2020 | 3429 | 0.120 |
Why?
|
Salvage Therapy | 1 | 2020 | 1264 | 0.110 |
Why?
|
Middle Aged | 15 | 2024 | 220774 | 0.110 |
Why?
|
Skull | 1 | 2017 | 818 | 0.110 |
Why?
|
Meningioma | 1 | 2021 | 1218 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8527 | 0.100 |
Why?
|
Horses | 2 | 2023 | 300 | 0.100 |
Why?
|
Texas | 1 | 2013 | 405 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 988 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1248 | 0.100 |
Why?
|
Sequence Analysis, DNA | 3 | 2020 | 4740 | 0.100 |
Why?
|
Genomics | 4 | 2024 | 5817 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1742 | 0.100 |
Why?
|
Survival Analysis | 2 | 2021 | 10075 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5665 | 0.100 |
Why?
|
Aged | 9 | 2024 | 169179 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2820 | 0.100 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2012 | 42 | 0.100 |
Why?
|
Cervical Vertebrae | 1 | 2017 | 981 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2644 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6473 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3685 | 0.090 |
Why?
|
Skin | 1 | 2024 | 4482 | 0.090 |
Why?
|
NF-kappa B | 1 | 2019 | 2488 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2012 | 296 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2612 | 0.090 |
Why?
|
Pyrimidines | 1 | 2022 | 3025 | 0.090 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2012 | 251 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2019 | 5670 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1833 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9605 | 0.080 |
Why?
|
Astrocytes | 1 | 2017 | 1346 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1114 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2012 | 502 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2448 | 0.080 |
Why?
|
Coronary Thrombosis | 1 | 2012 | 440 | 0.080 |
Why?
|
Biopsy | 3 | 2020 | 6768 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 696 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2020 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2017 | 1309 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4414 | 0.080 |
Why?
|
Epilepsy | 1 | 2023 | 3290 | 0.070 |
Why?
|
Age Factors | 2 | 2024 | 18401 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2012 | 1085 | 0.070 |
Why?
|
Thalidomide | 1 | 2012 | 885 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1533 | 0.070 |
Why?
|
Pediatrics | 1 | 2022 | 3594 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39108 | 0.070 |
Why?
|
Cholangiocarcinoma | 1 | 2012 | 552 | 0.070 |
Why?
|
Bile Duct Neoplasms | 1 | 2012 | 605 | 0.070 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3873 | 0.070 |
Why?
|
Losartan | 1 | 2008 | 265 | 0.070 |
Why?
|
Enalapril | 1 | 2008 | 313 | 0.070 |
Why?
|
Glomerulonephritis | 1 | 2008 | 336 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18234 | 0.060 |
Why?
|
Drug-Eluting Stents | 1 | 2012 | 680 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13635 | 0.060 |
Why?
|
Mice | 9 | 2024 | 81474 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5297 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 431 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2019 | 15879 | 0.060 |
Why?
|
RNA, Viral | 2 | 2023 | 2846 | 0.060 |
Why?
|
Animals | 12 | 2024 | 168388 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2012 | 1731 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4246 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13500 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6034 | 0.060 |
Why?
|
Neopterin | 1 | 2024 | 56 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2024 | 22124 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3796 | 0.060 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 3793 | 0.050 |
Why?
|
Pancreas | 1 | 2010 | 1689 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2012 | 2909 | 0.050 |
Why?
|
Neoplasms | 2 | 2024 | 22158 | 0.050 |
Why?
|
Renin-Angiotensin System | 1 | 2008 | 737 | 0.050 |
Why?
|
Claudins | 1 | 2024 | 117 | 0.050 |
Why?
|
Cell Membrane | 1 | 2012 | 3687 | 0.050 |
Why?
|
Preoperative Care | 1 | 2012 | 2242 | 0.050 |
Why?
|
Survival Rate | 3 | 2024 | 12710 | 0.050 |
Why?
|
Uridine | 1 | 2022 | 142 | 0.050 |
Why?
|
Phospholipase C beta | 1 | 2021 | 49 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2024 | 2811 | 0.050 |
Why?
|
RNA, Double-Stranded | 1 | 2023 | 295 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2012 | 1934 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3590 | 0.050 |
Why?
|
Signal Transduction | 3 | 2021 | 23427 | 0.050 |
Why?
|
Vesicular Transport Proteins | 1 | 2024 | 376 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1517 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16966 | 0.050 |
Why?
|
Phosphorylation | 1 | 2012 | 8312 | 0.040 |
Why?
|
Methionine | 1 | 2022 | 572 | 0.040 |
Why?
|
Liver Transplantation | 1 | 2012 | 2333 | 0.040 |
Why?
|
Long QT Syndrome | 1 | 2024 | 467 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 641 | 0.040 |
Why?
|
Facies | 1 | 2020 | 222 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2019 | 106 | 0.040 |
Why?
|
Codon | 1 | 2021 | 602 | 0.040 |
Why?
|
Chromatin | 2 | 2022 | 2960 | 0.040 |
Why?
|
Phenotype | 3 | 2022 | 16603 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 869 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 158 | 0.040 |
Why?
|
Brain Stem | 1 | 2024 | 858 | 0.040 |
Why?
|
Chromosomal Instability | 1 | 2019 | 178 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 186 | 0.040 |
Why?
|
Pons | 1 | 2019 | 240 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2023 | 1246 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2022 | 1494 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2019 | 427 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58946 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 426 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 785 | 0.040 |
Why?
|
Homozygote | 1 | 2022 | 1796 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5794 | 0.040 |
Why?
|
Neurosurgical Procedures | 2 | 2019 | 2071 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15262 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17872 | 0.040 |
Why?
|
Decompressive Craniectomy | 1 | 2017 | 76 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2021 | 1202 | 0.030 |
Why?
|
DNA Methylation | 2 | 2022 | 4383 | 0.030 |
Why?
|
Action Potentials | 1 | 2024 | 1834 | 0.030 |
Why?
|
Laminectomy | 1 | 2017 | 225 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21009 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 617 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1232 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 473 | 0.030 |
Why?
|
Epigenomics | 1 | 2021 | 941 | 0.030 |
Why?
|
Insulin | 1 | 2010 | 6595 | 0.030 |
Why?
|
Phylogeny | 1 | 2023 | 2809 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1223 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1624 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2392 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3603 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2019 | 719 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1611 | 0.030 |
Why?
|
Glycoproteins | 1 | 2022 | 2207 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1387 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2017 | 916 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1784 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2423 | 0.030 |
Why?
|
RNA | 1 | 2024 | 2723 | 0.030 |
Why?
|
Recurrence | 2 | 2019 | 8470 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 18962 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2509 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3639 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1218 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3588 | 0.030 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1861 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4120 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2017 | 856 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2012 | 154 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2022 | 1665 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3512 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1858 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1968 | 0.020 |
Why?
|
Hippocampus | 1 | 2023 | 3763 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2724 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4810 | 0.020 |
Why?
|
Massachusetts | 1 | 2023 | 8837 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11098 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6086 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5768 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14409 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7390 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36430 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5202 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7999 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2823 | 0.020 |
Why?
|
Hepatitis B, Chronic | 1 | 2012 | 410 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3538 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4423 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5866 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9319 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9534 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2115 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10431 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20092 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6309 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2012 | 4472 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 2751 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22154 | 0.010 |
Why?
|
Blood Glucose | 1 | 2014 | 6389 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10760 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 64645 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41440 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54405 | 0.010 |
Why?
|